05 Jul 2012 | 05:33 pm |
Pinsent Masons today announced preliminary details of its unaudited results for the financial year to 30 April 2012. Turnover was £221m, up 4% on the previous year (2010/2011: £212m).
That figure does not include turnover from the McGrigors business, which had a strong financial performance during the same period (McGrigors operated a September year end prior to the merger). Incorporating the recent financial results for McGrigors, the turnover for the combined firm in the last 12 months was £295m.
Commenting on the news, Pinsent Masons' Managing Partner David Ryan said:
"Our results show that we are continuing to perform strongly in a difficult market. The continued investment in our staff and infrastructure has increased our ability to respond to changing client demand. The merger with McGrigors built on this, and as a combined firm we are in a strong position for growth in the coming years."
In the final 7 months of operation McGrigors LLP posted revenues of £42.5m, leaving it on course to post increased turnover relative to its 2010/11 figure of £70m.
Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.
Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.
Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).
Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.
Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.
Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]